Physician profile
Salah Beck
NPI 1497142103
$2,645.20
in general payments reported to CMS, 2019-2025
29 companies · $599 in 2025
The $599 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $32.69 · 2021: $239 · 2022: $547 · 2023: $784 · 2024: $335 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,624 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,624.37 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $439.84 | 2021-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $369.04 | 2022-2025 | |
| Pfizer INC. | $315.05 | 2021-2024 | |
| Shield Therapeutics INC | $178.20 | 2023-2025 | Accrufer |
| Sage Therapeutics, LLC | $168.93 | 2025 | Zurzuvae |
| Channel Medsystems, INC. | $160.87 | 2022-2023 | |
| Abbvie INC. | $155.26 | 2019-2024 | Liletta |
| Exeltis, USA INC. | $131.84 | 2021-2025 | Slynd |
| Conmed Corporation | $94.36 | 2019-2024 | Airseal |
| Axonics, INC. | $70.72 | 2023-2024 | Axonics |
| Sumitomo Pharma America, INC. | $61.34 | 2023-2025 | Gemtesa, Myfembree |
| Aspira Women'S Health INC | $60.73 | 2022 | |
| Daiichi Sankyo INC. | $51.27 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $45.41 | 2025 | Qelbree |
| Exact Sciences Corporation | $37.97 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $37.68 | 2023 | Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $35.84 | 2025 | |
| Boston Scientific Corporation | $32.38 | 2025 | Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous) |
| Hologic Sales and Service, LLC | $25.11 | 2021 | |
| Organon LLC | $23.51 | 2022 | |
| Millicent US INC | $21.41 | 2025 | Intrarosa |
| Roche Diagnostics Corporation | $18.30 | 2021 | |
| Monaghan Medical Corporation | $18.28 | 2023 | Aerochamber |
| Baxter Healthcare | $18.08 | 2022 | |
| Smith+Nephew, INC. | $15.73 | 2021 | |
| Coopersurgical, INC. | $15.55 | 2025 | Paragard T 380a |
| Mylan Pharmaceuticals INC. | $15.31 | 2021 | |
| Myovant Sciences INC. | $14.55 | 2022 | |
| Urovant Sciences INC | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salah Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.